We are live on ! Find out more
NIM

NEOS Investment Management Portfolio holdings

AUM $27.1B
1-Year Est. Return 57.21%
This Fund
S&P 500
This Quarter Est. Return
+13.42%
1 Year Est. Return
+57.21%
3 Year Est. Return
+163.05%
5 Year Est. Return
10 Year Est. Return
AUM
$1.61B
AUM Growth
+$558M
Cap. Flow
+$437M
Cap. Flow %
27.05%
Top 10 Hldgs %
34.09%
Holding
582
New
73
Increased
454
Reduced
38
Closed
16

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$29.1M
2
AAPL icon
Apple
AAPL
+$26.2M
3
NVDA icon
NVIDIA
NVDA
+$19.5M
4
AMZN icon
Amazon
AMZN
+$16.9M
5
META icon
Meta Platforms (Facebook)
META
+$10.3M

Sector Composition

Rank Sector Weight
1 Technology 34.78%
2 Healthcare 14.59%
3 Communication Services 10.45%
4 Consumer Discretionary 10.42%
5 Financials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTU icon
26
Intuit
INTU
$88B
$10.6M 0.66%
16,311
+2,701
+20% +$1.72M
AMAT icon
27
Applied Materials
AMAT
$334B
$10.1M 0.62%
48,900
+9,485
+24% +$1.74M
MA icon
28
Mastercard
MA
$502B
$10.1M 0.62%
20,914
+9,190
+78% +$4.2M
VRTX icon
29
Vertex Pharmaceuticals
VRTX
$130B
$9.99M 0.62%
23,890
+9,490
+66% +$4.01M
CMCSA icon
30
Comcast
CMCSA
$86.7B
$9.98M 0.62%
230,146
+40,861
+22% +$1.76M
HD icon
31
Home Depot
HD
$305B
$9.66M 0.6%
25,182
+6,806
+37% +$2.49M
JNJ icon
32
Johnson & Johnson
JNJ
$644B
$9.61M 0.6%
60,749
+22,438
+59% +$3.57M
PG icon
33
Procter & Gamble
PG
$341B
$9.6M 0.59%
59,167
+21,521
+57% +$3.38M
MRK icon
34
Merck
MRK
$355B
$9.53M 0.59%
72,244
+23,627
+49% +$2.91M
TXN icon
35
Texas Instruments
TXN
$241B
$9.12M 0.57%
52,372
+9,554
+22% +$1.59M
TMUS icon
36
T-Mobile US
TMUS
$194B
$8.39M 0.52%
51,402
+6,000
+13% +$977K
ISRG icon
37
Intuitive Surgical
ISRG
$133B
$8.16M 0.51%
20,449
+3,831
+23% +$1.45M
ABBV icon
38
AbbVie
ABBV
$465B
$8.08M 0.5%
44,369
+19,313
+77% +$3.33M
MU icon
39
Micron Technology
MU
$1.05T
$7.6M 0.47%
64,458
+12,528
+24% +$1.13M
HON icon
40
Honeywell
HON
$64.5B
$7.59M 0.47%
39,247
+1,757
+5% +$331K
REGN icon
41
Regeneron Pharmaceuticals
REGN
$79.7B
$7.32M 0.45%
7,610
+1,534
+25% +$1.46M
CRM icon
42
Salesforce
CRM
$210B
$7.2M 0.45%
23,902
+5,875
+33% +$1.7M
LRCX icon
43
Lam Research
LRCX
$339B
$7.11M 0.44%
73,170
+8,830
+14% +$777K
CVX icon
44
Chevron
CVX
$427B
$6.99M 0.43%
44,295
+15,087
+52% +$2.28M
BAC icon
45
Bank of America
BAC
$416B
$6.6M 0.41%
173,925
+76,339
+78% +$2.62M
WMT icon
46
Walmart Inc
WMT
$858B
$6.47M 0.4%
107,505
+34,212
+47% +$1.96M
SBUX icon
47
Starbucks
SBUX
$110B
$6.04M 0.37%
66,132
+12,501
+23% +$1.16M
KO icon
48
Coca-Cola
KO
$382B
$6M 0.37%
97,993
+38,734
+65% +$2.33M
DXCM icon
49
DexCom
DXCM
$32.6B
$5.97M 0.37%
43,010
+19,119
+80% +$2.4M
GILD icon
50
Gilead Sciences
GILD
$181B
$5.88M 0.36%
80,305
+14,494
+22% +$1.11M

Similar funds

NEOS Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, NEOS Investment Management held 582 positions worth $1.61B, up 53% from $1.06B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

NEOS Investment Management deployed $437M of net new capital in Q1 2024, opening 73 new positions and adding to 454 existing holdings. Its largest new stake was Keros Therapeutics: 14,264 shares worth $944K.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Goldman Sachs, an estimated $583K trimmed.

  • NEOS Investment Management's largest Q1 2024 buy was Keros Therapeutics: 14,264 shares worth $944K.
  • NEOS Investment Management added most to Microsoft in Q1 2024, an estimated $29.1M increase.
  • NEOS Investment Management's biggest Q1 2024 reduction was Goldman Sachs, cutting an estimated $583K.
  • NEOS Investment Management fully exited Vanguard Russell 2000 ETF in Q1 2024, selling an estimated $12.5M.
  • NEOS Investment Management's ten largest holdings make up 34% of its $1.61B portfolio in Q1 2024.
  • NEOS Investment Management opened 73 new positions and closed 16 in Q1 2024.
  • NEOS Investment Management's portfolio value rose 53% quarter-over-quarter to $1.61B.

Based on NEOS Investment Management's 13F filing for Q1 2024, filed 13 May 2024.